Capas, Mark Paul S.
HRN: 14-88-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2025
CEFUROXIME 1.5GM (VIAL)
01/10/2025
01/17/2025
IV
950mg
Q8hrs
Snake Bite
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes